期刊文献+

乳腺癌扩增基因1与上皮细胞钙黏蛋白在卵巢癌组织中的表达及其临床意义 被引量:1

Expression and clinical significance of amplified in breast cancer 1 and epithelial cadherin in ovarian carcinoma tissues
原文传递
导出
摘要 目的检测乳腺癌扩增基因1(Mm)与上皮细胞钙黏蛋白(E—cadherin)在卵巢癌组织中的表达,并确定其表达与卵巢癌临床病理特征的关系。方法采用免疫组织化学EnVision二步法染色检测50例卵巢癌组织和13例正常卵巢组织中AIB1、E—cadherin、雌激素受体(ER)、孕激素受体(PR)与Ki。67等的表达。结果卵巢癌组织中AIB1阳性表达率[68%(34/50)]显著高于正常卵巢组织[8%(1/13)](P〈0.01),E-cadherin表达下调率为60%(30/50)。AIB1阳性表达率在国际妇产科联盟(FIGO)分期Ⅲ+Ⅳ期高于Ⅰ+Ⅱ期(P=0.036),有淋巴结转移高于无淋巴结转移(P=0.027),Silverberg分期G,期高于G。+G2期(P:0.003),浆液性腺癌高于非浆液性腺癌(P=0.049),ER阳性高于ER阴性(P=0.000),Ki-67阳性高于Ki.67阴性(P=0.009);E—cadherin表达下调率在FIGO分期Ⅲ+Ⅳ期高于I+Ⅱ期(P=0.044),浆液性腺癌高于非浆液性腺癌(P=0.002),ER阳性高于ER阴性(P=0.021),Ki.67阳性高于Ki.67阴性(P=0.035)。AIB1与E-cadherin表达呈负相关(P=0.026)。结论卵巢癌组织中AIB1与E—cadherin表达情况及临床分期密切相关,可能是参与卵巢癌发展的重要分子。 Objective To examine the expressions of amplified in breast cancer 1 (AIB1) and epithelial cadherin (E-cadherin) in ovarian carcinoma (OC) tissues, and determine the correlation between the expression and clinical pathological features. Methods The expression of AIB1 ,E-cadherin,estrogen receptor (ER), progesterone receptor (PR) and Ki-67 in tissues of 50 OCs and 13 normal ovarians tissues were detected by immunohistochemistry (IHC) EnVision two step process analysis. Results Positive expression of AIB 1 in OC tissues [ 68% (34/50)] was obviously higher than that in normal ovarian tissues [8% (1/13)] (P 〈0.01). Down-regulation of E-cadherin expression was 60% (30/50). The positive expression of AIB1 was significantly higher in stage Ⅲ and Ⅳ than in stage I and Ⅱ according to International Federation of Gynecology and Obstetrics (FIGO) stage (P = 0.036), in lymph node metastasis group than in none lymph node metastasis group(P = 0.027), in stage G3 than in stage G1 and G2 according to Silverberg stage (P = 0.003 ), and in serous adenocarcinoma group than in non-serous adenocarcinoma group(P = 0.049) ;positive rates of ER and Ki-67 were higher than negative rates of ER (P = 0.000) and Ki-67 (P = 0.009) respectively. Down-regulation of E-cadherin expression was higher in FIGO stage m and Ⅳ than in stage I and Ⅱ (P = 0.044), in serous adenocarcinoma group than in nonserous adenocarcinoma group (P = 0.022) ;positive rates of ER and Ki-67 were higher than negative rates of ER (P = 0.021 ) and Ki-67 (P = 0.035) respectively. The expression of AIB 1 was negatively correlated with E-cadherin expression (P = 0.026). Conclusions The expressions of AIB1 and E-cadherin in OC tissues is closely related to clinical stage. Therefore, AIB 1 and E-cadherin may be important moleculars involved in the progression of OC.
出处 《中国医师进修杂志》 2012年第15期1-5,共5页 Chinese Journal of Postgraduates of Medicine
基金 广东省科技计划项目(20098030801317) 广东省医学科研基金项目(B2010228) 汕头大学医学院附属肿瘤医院青年基金资助项目[汕大医肿瘤医(2009)5号]
关键词 卵巢肿瘤 基因扩增 上皮细胞钙黏蛋白 Ovarian neoplasms Gene amplification Epithelial cadherin
  • 相关文献

参考文献16

  • 1O'Malley BW. Coregulators:from whence came these "master genes". Mol Endocrinol, 2007,21 (5) : 1009-1013. 被引量:1
  • 2Cheng JC,Auersperg N,Leung PC. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor ceils. Oncogene, 2011,30(37 ) : 3930-3942. 被引量:1
  • 3Xu FP,Xie D,Wen JM,et al. SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas. Cancer Lett, 2007,245 ( 1/2 ) : 69-74. 被引量:1
  • 4Takeno S,Noguehi T,Fumoto S,et al. E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications. Am J Clin Pathol, 2004, 122( 1 ) : 78-84. 被引量:1
  • 5Chien CD,Kirilyuk A,Li JV,et al. Role of the nuclear receptor coactivator AIB1-Deha4 splice variant in the control of gene transcription. J Biol Chem, 2011,286(30) : 26813-26827. 被引量:1
  • 6Ma G,Ren Y,Wang K,et al. SRC-3 has a role in cancer other than as a nuclear receptor coactivator. Int J Biol Sci, 2011,7 (5) : 664- 672. 被引量:1
  • 7Torres-Arzayus MI,Zhao J, Bronson R,et al. Estrogen-dependent and estrogen-independent mechanisms contribute to AIB 1-mediated tumor formation. Cancer Res, 2010,70(10) : 4102-4111. 被引量:1
  • 8Fasching PA, Heusinger K, Haberle L,et al. Ki67,chemotherapy response,and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer, 2011,11 ( 1 ) : 486. 被引量:1
  • 9Harigopal M,Heymann J, Ghosh S,et al. Estrogen receptor co- activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Breast Cancer Res Treat, 2009,115 ( 1 ) : 77- 85. 被引量:1
  • 10Sakaguchi H,Fujimoto J,Sun WS,et al. Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol,2007,104(3/5 ):237-240. 被引量:1

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部